Product
Leritrelvir(Ray1216)
1 clinical trial
1 indication
Indication
Liver ImpairmentClinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Leritrelvir(RAY1216)Status: Completed, Estimated PCD: 2023-10-01